Published in J Lipid Res on July 01, 1988
Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2012) 2.49
Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest (1991) 1.64
Impaired ability of patients with familial isolated vitamin E deficiency to incorporate alpha-tocopherol into lipoproteins secreted by the liver. J Clin Invest (1990) 1.31
Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding. J Clin Invest (1990) 1.24
Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. Cardiovasc Diabetol (2014) 1.14
Nutritional lipidomics: molecular metabolism, analytics, and diagnostics. Mol Nutr Food Res (2013) 1.03
Dietary fructose and glucose differentially affect lipid and glucose homeostasis. J Nutr (2009) 1.02
Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci U S A (1993) 0.97
Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet (1994) 0.94
Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects. Metabolism (2009) 0.89
Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins. J Clin Invest (1990) 0.89
Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. J Clin Invest (1996) 0.88
Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus. J Lipid Res (2009) 0.86
Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels. Atherosclerosis (2008) 0.85
Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest (1993) 0.81
Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial. Diabetes Care (2012) 0.81
Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families. J Clin Invest (1991) 0.80
The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice. PLoS One (2012) 0.79
Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women. Metabolism (2007) 0.78
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med (1999) 9.83
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68
Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol (1986) 3.35
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA (2001) 3.12
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA (1994) 3.11
Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta (1987) 2.70
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49
Quantification of mRNA by polymerase chain reaction (PCR) using an internal standard and a nonradioactive detection method. Methods Mol Biol (1998) 2.39
Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med (1999) 2.33
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
Pathogenesis and management of lipoprotein disorders. N Engl J Med (1985) 2.31
Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest (1986) 2.21
Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr (2007) 2.10
Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol (2000) 2.10
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology (1996) 2.00
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol (1984) 1.99
Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest (1986) 1.98
Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham study. Hum Mol Genet (2000) 1.94
Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr (2000) 1.87
Familial apolipoprotein E deficiency. J Clin Invest (1986) 1.87
Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation (1992) 1.84
Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science (1981) 1.84
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis (2001) 1.84
Lack of efficacy of a food-frequency questionnaire in assessing dietary macronutrient intakes in subjects consuming diets of known composition. Am J Clin Nutr (2000) 1.76
How reliably can compact chemistry analyzers measure lipids? JAMA (1990) 1.73
Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA (1994) 1.71
Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Engl J Med (1986) 1.70
Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res (1988) 1.67
Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol (1996) 1.65
Epidemiology of dental trauma: a review of the literature. Aust Dent J (2000) 1.64
Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem (1999) 1.64
Absence of P-selectin delays fatty streak formation in mice. J Clin Invest (1997) 1.63
Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res (1994) 1.62
Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol (1996) 1.60
Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis (1982) 1.57
Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am J Clin Nutr (1997) 1.54
Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb (1992) 1.52
Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol (2000) 1.49
Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res (1987) 1.49
Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet. JAMA (1995) 1.48
Lipoprotein apoprotein metabolism. J Lipid Res (1978) 1.48
Prevalence of risk factors in men with premature coronary artery disease. Am J Cardiol (1991) 1.47
Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I). Biochem Biophys Res Commun (1980) 1.46
Summary of a scientific conference on preventive nutrition: pediatrics to geriatrics. Circulation (1999) 1.46
Linkage, evolution, and expression of the rat apolipoprotein A-I, C-III, and A-IV genes. J Biol Chem (1986) 1.44
Beta-glucocerebrosidase gene locus as a link for Gaucher's disease and familial hypo-alpha-lipoproteinaemia. Lancet (1998) 1.44
Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem (1996) 1.43
Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol (1999) 1.43
Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). Ann Intern Med (1980) 1.41
Diet and exercise and gemfibrozil therapy for the management of dyslipidemia: a CEN study. Clinical Experience Network. J Fam Pract (1993) 1.39
Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem (1990) 1.37
NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann Intern Med (1983) 1.36
Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem (1996) 1.35
Human chylomicron apolipoprotein metabolism. Biochem Biophys Res Commun (1978) 1.34
Human apolipoprotein A-I and A-II metabolism. J Lipid Res (1982) 1.32
Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E. Science (1981) 1.29
Genetic variation at the perilipin (PLIN) locus is associated with obesity-related phenotypes in White women. Clin Genet (2004) 1.28
Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis (2001) 1.27
Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis (1987) 1.26
Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding. J Clin Invest (1990) 1.24
Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation (1993) 1.24
LDL particle size distribution. Results from the Framingham Offspring Study. Arterioscler Thromb (1992) 1.24